drugset / Trial / NCT00005816

Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer

NCT00005816

Treatment

Summary

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have stage III or stage IV kidney cancer.

Timeline

Start
2000-02
Primary completion
Completion
2002-08

Drugs

EvaluationDrugModalityDoseRoute
Subject therapeutic autologous dendritic cells Vaccine Intravenous

Indications